Sfoglia per AUTORE
LUS G
Collezione AOU San Luigi di Orbassano

  

Items : 19

Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA). in Journal of neurology / J Neurol. 2024 Oct;271(10):6801-6810. doi: 10.1007/s00415-024-12621-9. Epub 2024 Aug 27.
2024
AOU San Luigi di Orbassano

Chisari CG; Amato MP; Di Sapio A; Foschi M; Iaffaldano P; Inglese M; Fermo SL; Lugaresi A; Lus G; Mascoli N; Montepietra S; Pesci I; Quatrale R; Salemi G; Torri Clerici V; Totaro R; Valentino P; Filippi M; Patti F;

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry. in Journal of neurology / J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ferraro D; Gasperini C; Salemi G; Bergamaschi R; Lus G; Inglese M; Romano S; Bellantonio P; Di Monte E; Maniscalco GT; Conte A; Lugaresi A; Trojano M; Filippi M; Amato MP; Nica M; Ragonese P; Ruggieri S; Carotenuto A; Tortorella C; Fenu G; Onofrj M; Portaccio E; Chisari CG; Rocca MA; Ardito B; Banfi P; Nasuelli D; Paolicelli D; et alii...

Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study. in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2024 Jul;21(4):e00363. doi: 10.1016/j.neurot.2024.e00363. Epub 2024 May 7.
2024
AOU San Luigi di Orbassano

Chisari CG; Aguglia U; Amato MP; Bergamaschi R; Bertolotto A; Bonavita S; Morra VB; Cavalla P; Cocco E; Conte A; Cottone S; De Luca G; Di Sapio A; Filippi M; Gallo A; Gasperini C; Granella F; Lus G; Maimone D; Maniscalco GT; Marfia G; Moiola L; Paolicelli D; Pesci I; Ragonese P; Rovaris M; Salemi G; Solaro C; Totaro R; et alii...

COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients. in Journal of neurology / J Neurol. 2024 Feb;271(2):699-710. doi: 10.1007/s00415-023-12084-4. Epub 2023 Nov 20.
2024
AOU San Luigi di Orbassano

Mascolo A; Copetti M; Trojano M; Patti F; Mirabella M; Marfia GA; Lus G; Granella F; Filippi M; De Luca G; Capobianco M; Matrone F; Bisecco A; Tedeschi G; Gallo A;

Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study. in Journal of neurology / J Neurol. 2023 Oct;270(10):4687-4696. doi: 10.1007/s00415-023-11820-0. Epub 2023 Jul 5.
2023
AOU San Luigi di Orbassano

Amato MP; Bergamaschi R; Centonze D; Mirabella M; Marfia GA; Totaro R; Lus G; Brescia Morra V; Aguglia U; Comi C; Cavalla P; Zaffaroni M; Rovaris M; Grimaldi LM; Leoni S; Malucchi S; Baldi E; Romano M; Falcini M; Perini P; Assetta M; Portaccio E; Sommacal S; Olivieri N; Parodi F; Todaro DS; Grassivaro N; Farina A; Mondino MM; et alii...

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.
2022
AOU San Luigi di Orbassano

Landi D; Bovis F; Grimaldi A; Annovazzi PO; Bertolotto A; Bianchi A; Borriello G; Brescia Morra V; Bucello S; Buscarinu MC; Caleri F; Capobianco M; Capra R; Cellerino M; Centonze D; Cerqua R; Chisari CG; Clerico M; Cocco E; Cola G; Cordioli C; Curti E; d'Ambrosio A; D'Amico E; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; et alii...

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration. in Journal of neurology / J Neurol. 2022 Mar;269(3):1463-1469. doi: 10.1007/s00415-021-10708-1. Epub 2021 Jul 22.
2022
AOU San Luigi di Orbassano

Vitetta F; Pisano E; Malucchi S; Cavalla P; Cellerino M; Patti F; Lus G; Mirabella M; Zaffaroni M; Brescia Morra V; Capobianco M; Inglese M; Guerra T; Iaffaldano P; Ferraro D; Paolicelli D; Sola P; Trojano M;

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141. doi: 10.1212/NXI.0000000000001141. Print 2
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Trojano M; Amato MP; Filippi M; Battaglia MA; Comi G; Tedeschi G; Ponzio M; Mosconi P; Lepore V; Ferraro D; Moiola L; Petracca M; Malucchi S; Toscano S; Totaro R; Brambilla L; Vianello M; Ragonese P; Granella F; Maniscalco GT; Montepietra S; Cavalla P; Lugaresi A; De Luca G; Lus G; Pesci I; Sola P; Brescia Morra V; Capobianco M; et alii...

A real-world study of alemtuzumab in a cohort of Italian patients. in European journal of neurology / Eur J Neurol. 2022 Jan;29(1):257-266. doi: 10.1111/ene.15121. Epub 2021 Oct 5.
2022
AOU San Luigi di Orbassano

Russo CV; Saccà F; Frau J; Annovazzi P; Signoriello E; Bonavita S; Grasso R; Clerico M; Cordioli C; Laroni A; Capobianco M; Torri Clerici V; Sartori A; Cavalla P; Maniscalco GT; La Gioia S; Caleri F; Giugno A; Iodice R; Carotenuto A; Cocco E; Fenu G; Zaffaroni M; Baroncini D; Lus G; Gallo A; De Mercanti SF; Lapucci C; Di Francescantonio V; et alii...

2022
ASL Cuneo 1
AOU San Luigi di Orbassano

Bellantonio P; Totaro R; Vianello M; Cavalla P; Granella F; Di Sapio A; Bertolotto A; Maimone D; Bergamaschi R; Lus G; Solaro C; Amato MP; Rovaris M; Gasperini C; Ferrò MT; Pesci I; Aguglia U; Maniscalco GT; Sola P; Conte A; De Luca G; Cottone S; Salemi G; Lugaresi A; Inglese M; Bonavita S; Grimaldi LM; Marfia GA; Brescia Morra V; et alii...

MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study. in Journal of the neurological sciences / J Neurol Sci. 2021 May 15;424:117385. doi: 10.1016/j.jns.2021.117385. Epub 2021 Mar 6.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sartori A; Frangiamore R; Laroni A; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Cocco E; Lorefice L; Maniscalco GT; Curti E; Lavorgna L; Abbadessa G; Bonavita S; Lus G; Signoriello E; Cordioli C; Signori A; De Mercanti SF; Cavalla P; Costantini G; Capra R; Sormani MP; Clerico M;

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies. in Therapeutic advances in neurological disorders / Ther Adv Neurol Disord. 2021 May 31;14:17562864211019574. doi: 10.1177/17562864211019574. eCollectio
2021
AOU San Luigi di Orbassano

Iaffaldano P; Lucisano G; Caputo F; Paolicelli D; Patti F; Zaffaroni M; Brescia Morra V; Pozzilli C; De Luca G; Inglese M; Salemi G; Maniscalco GT; Cocco E; Sola P; Lus G; Conte A; Amato MP; Granella F; Gasperini C; Bellantonio P; Totaro R; Rovaris M; Salvetti M; Torri Clerici VLA; Bergamaschi R; Maimone D; Scarpini E; Capobianco M; Comi G; et alii...

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):914-920. doi: 10.1136/jnnp-2019-322480. Epub 2020 Jul
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Spinicci G; Spitaleri D; Sessa E; Rovaris M; Righini I; Pontecorvo S; Petrucci L; Matta M; Paolicelli D; Maniscalco GT; Lus G; Lanzillo R; Guareschi A; Gasperini C; Gajofatto A; Esposito F; Danni MC; Cottone S; Centonze D; Costantino G; Castelli L; Cavalla P; Capello E; Bruno Bossio R; Brescia Morra V; Bonavita S; Bianco A; Bergamaschi R; Annunziata P; et alii...

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2020 Jan;17(1):200-207. doi: 10.1007/s13311-019-00776-7.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sartori A; Laroni A; Frangiamore R; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Lorefice L; Cocco E; Curti E; Maniscalco GT; Lavorgna L; Bonavita S; Lus G; Signoriello E; Cordioli C; Signori A; Iudicello M; De Mercanti SF; Clerico M; Cavalla P; Costantini G; Sormani MP; Capra R;

2019
AOU San Luigi di Orbassano

Paolicelli D; Lucisano G; Manni A; Avolio C; Bonavita S; Brescia Morra V; Capobianco M; Cocco E; Conte A; De Luca G; De Robertis F; Gasperini C; Gatto M; Gazzola P; Lus G; Iaffaldano A; Iaffaldano P; Maimone D; Mallucci G; Maniscalco GT; Marfia GA; Patti F; Pesci I; Pozzilli C; Rovaris M; Salemi G; Salvetti M; Spitaleri D; Totaro R; et alii...

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study. in Journal of neurology / J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.
2018
AOU San Luigi di Orbassano

Prosperini L; Annovazzi P; Boffa L; Buscarinu MC; Gallo A; Matta M; Moiola L; Musu L; Perini P; Avolio C; Barcella V; Bianco A; Farina D; Ferraro E; Pontecorvo S; Granella F; Grimaldi LME; Laroni A; Lus G; Patti F; Pucci E; Pasca M; Sarchielli P;

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):944-51. doi: 10.1136/jnnp-2015-312591. Epub 2016 May 9
2016
AOU San Luigi di Orbassano

Patti F; Messina S; Solaro C; Amato MP; Bergamaschi R; Bonavita S; Bruno Bossio R; Brescia Morra V; Costantino GF; Cavalla P; Centonze D; Comi G; Cottone S; Danni M; Francia A; Gajofatto A; Gasperini C; Ghezzi A; Iudice A; Lus G; Maniscalco GT; Marrosu MG; Matta M; Mirabella M; Montanari E; Pozzilli C; Rovaris M; Sessa E; Spitaleri D; et alii...

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study. in Journal of neurology / J Neurol. 2016 Sep;263(9):1727-35. doi: 10.1007/s00415-016-8188-y. Epub 2016 Jun 10.
2016
AOU San Luigi di Orbassano

Moiola L; Annovazzi P; Capobianco M; Patti F; Frau J; Uccelli A; Centonze D; Perini P; Tortorella C; Prosperini L; Lus G; Fuiani A; Falcini M; Martinelli V; Comi G; Ghezzi A;

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis. in Brain : a journal of neurology / Brain. 2015 Nov;138(Pt 11):3275-86. doi: 10.1093/brain/awv260. Epub 2015 Sep 11.
2015
AOU San Luigi di Orbassano

Iaffaldano P; Lucisano G; Pozzilli C; Brescia Morra V; Ghezzi A; Millefiorini E; Patti F; Lugaresi A; Zimatore GB; Marrosu MG; Amato MP; Bertolotto A; Bergamaschi R; Granella F; Coniglio G; Tedeschi G; Sola P; Lus G; Ferrò MT; Iuliano G; Corea F; Protti A; Cavalla P; Guareschi A; Rodegher M; Paolicelli D; Tortorella C; Lepore V; Prosperini L; et alii...